Bringing information into the cell

April 25, 2019

Researchers at the Paul Scherrer Institute PSI have elucidated an important part of a signal pathway that transmits information through the cell membrane into the interior of a cell.

The interior of all living cells is separated from the outside world by membranes. These membranes keep the cells intact and protect them from negative influences. But they also act as a barrier for nutrients and information. For this reason, cell membranes contain mechanisms that enable selective access to desired substances or transmit information from external signals into the cell.

An important signal pathway in mammals consists of three components: The first is a receptor that recognises the signal and is activated by it. The second is a so-called G protein that binds to the activated receptor and transmits the signal to one or more effector proteins. In this case, the effector is adenylyl cyclase, the third component of the signal chain. This protein is activated by a subunit of the G protein and produces, in a biochemical reaction, a secondary messenger called cyclic AMP (cAMP).

cAMP triggers various reactions in the cell; for example, it increases the permeability of the membrane to calcium in cardiac cells, leading to an increase in the heart beat rate.

Researchers at the Paul Scherrer Institute in Villigen, Switzerland, have now examined one special type of adenylyl cyclase with the help of electron microscopy and have produced the most detailed image to date of this type of membrane protein.

Helpful self-restraint

"To understand how signal pathways in the cell work, it is necessary first to know what the components involved look like in detail", says Volodymyr Korkhov, head of the research group Mechanisms of Signal Transduction in the Biology and Chemistry Division at PSI and assistant professor at the Institute for Biochemistry at ETH Zurich. "Our work is an important contribution to elucidating the exact function of adenylyl cyclase in the cAMP signal chain."

"Surprisingly, in determining the structure of the adenylyl cyclase bound to the alpha subunit of the G protein, we discovered that the protein appears to be able to inhibit itself", says Korkhov. One part of the protein is responsible for this self-inhibition. This part blocks the active site of the enzyme and prevents the overproduction of cAMP.

This new insight into the molecular structure of adenylyl cyclase provides a much better understanding of how external signals lead to the controlled production of the important secondary messenger cAMP. The concentration of cAMP in cells plays an important role in the development of cardiovascular diseases, certain tumours, and type 2 diabetes. "In the future, our new findings could make it possible to identify drugs that inhibit or activate the adenylyl cyclase, depending on whether overproduction or lack of cAMP is responsible for a disease", Korkhov explains.

Microscopy at low temperatures

The researchers achieved their results using cryo-electron microscopy (cryo-EM). This form of transmission electron microscopy operates at temperatures below -150 degrees Celsius. The sample to be examined is snap frozen in liquid ethane, preserving its natural structure. This method, for which the Nobel Prize for Chemistry was awarded in 2017, is increasingly used in the investigation of biological structures. "It is exciting to get a deep insight into the structure of adenylate cyclase", says Chao Qi, a doctoral candidate in Korkhov's lab and first author of the study. "The structure of this protein has been elusive for decades since its discovery, and I'm glad that I was able to elucidate this structure with cryo-EM in the course of my doctoral research."

The resolution achieved by the PSI researchers in their investigations was 3.4 angstroms. An angstrom is one ten-millionth of a millimetre. Isolated atoms have a radius of 0.3 to 3 angstroms.

The researchers have now published their findings in the scientific journal Science.
-end-
Text: Paul Scherrer Institute/Sebastian Jutzi

Images are available to download at https://www.psi.ch/en/media/images-download

About PSI

The Paul Scherrer Institute PSI develops, builds and operates large, complex research facilities and makes them available to the national and international research community. The institute's own key research priorities are in the fields of matter and materials, energy and environment and human health. PSI is committed to the training of future generations. Therefore about one quarter of our staff are post-docs, post-graduates or apprentices. Altogether PSI employs 2100 people, thus being the largest research institute in Switzerland. The annual budget amounts to approximately CHF 390 million. PSI is part of the ETH Domain, with the other members being the two Swiss Federal Institutes of Technology, ETH Zurich and EPFL Lausanne, as well as Eawag (Swiss Federal Institute of Aquatic Science and Technology), Empa (Swiss Federal Laboratories for Materials Science and Technology) and WSL (Swiss Federal Institute for Forest, Snow and Landscape Research).

Contact

Prof. Dr. Volodymyr Korkhov
Research Group Mechanisms of Signal Transduction
Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen PSI, Switzerland
Telephone: +41 56 310 28 42, E-mail: volodymyr.korkhov@psi.ch [English]

Original Publication

The structure of a membrane adenylyl cyclase bound to an activated stimulatory G protein
Chao Qi, Simona Sorrentino, Ohad Medalia, Volodymyr M. Korkhov
Science 26.04.2019
DOI: 10.1126/science.aav0778

Paul Scherrer Institute

Related Diabetes Articles from Brightsurf:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.